Your browser doesn't support javascript.
loading
Optochemogenetics (OCG) allows more precise control of genetic engineering in mice with CreER regulators.
Lu, Xin; Agasti, Sarit S; Vinegoni, Claudio; Waterman, Peter; DePinho, Ronald A; Weissleder, Ralph.
Affiliation
  • Lu X; Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77054, USA.
Bioconjug Chem ; 23(9): 1945-51, 2012 Sep 19.
Article in En | MEDLINE | ID: mdl-22917215
ABSTRACT
New approaches that allow precise spatiotemporal control of gene expression in model organisms at the single cell level are necessary to better dissect the role of specific genes and cell populations in development, disease, and therapy. Here, we describe a new optochemogenetic switch (OCG switch) to control CreER/loxP-mediated recombination via photoactivatable ("caged") tamoxifen analogues in individual cells in cell culture, organoid culture, and in vivo in adult mice. This approach opens opportunities to more fully exploit existing CreER transgenic mouse strains to achieve more precise temporal- and location-specific regulation of genetic events and gene expression.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Engineering Limits: Animals Language: En Journal: Bioconjug Chem Journal subject: BIOQUIMICA Year: 2012 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Engineering Limits: Animals Language: En Journal: Bioconjug Chem Journal subject: BIOQUIMICA Year: 2012 Document type: Article Affiliation country: United States